🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pelvic Tumor

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology NCT05756569Phase 24 sites📍 Atlanta📍 Atlanta📍 Atlanta Emory University · Tests: Biospecimen Collection, Computed Tomography, Enfortumab Vedotin, Magnetic Resonance Imaging, Pembrolizumab Delayed Pelvic Imaging With [68]Ga-PSMA PET/CT in a Patient With High-risk Prostate Cancer. NCT07357259NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Intervention Group Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma NCT05603910Phase 11 site📍 Miami Aaron Wolfson · Tests: Lenvatinib, Pembrolizumab, Hypofractionated External Beam Radiation Therapy, High-Dose Rate (HDR) Brachytherapy Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy NCT06024109n/a2 sites📍 Frankfurt am Main📍 Manresa Aesculap AG · Tests: Closure of the Vaginal Cuff after Total Hysterectomy European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III NCT04504006n/a1 site📍 Essen Dr. Paul Buderath · Tests: Peritoneal Mesometrial Resetion + Targeted Compartmental Lymphadenectomy (PMMR+TCL) Adaptive Radiation for Abdominopelvic Metastases NCT05880667Phase 11 site📍 Philadelphia Fox Chase Cancer Center · Tests: Adaptive Stereotactic Body Radiation uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto NCT05874921n/a22 sites📍 Santa Monica📍 Gainesville📍 Miami UroGen Pharma Ltd. · Tests: Jelmyto (mitomycin) for pyelocalyceal solution Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs NCT06652022NA2 sites📍 Beijing📍 Beijing Peking University First Hospital · Tests: Systematic therapy combined with radiotherapy, Systematic drug treatment Beyond TME Origins NCT02292641NA4 sites📍 Oslo📍 Harrow📍 Oxford Imperial College London · Tests: New Radiological Staging Classification system for patients with advanced and recurrent colorectal cancer undergoing pe… Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC NCT06598761n/a2 sites📍 Beijing📍 Beijing Peking University First Hospital · Tests: Immunotherapy+radiotherapy, surveillance alone A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer NCT05691010EARLY Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intensity-modulated radiation therapy, Carboplatin, Paclitaxel Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain NCT05868668NA1 site📍 Cleveland The Cleveland Clinic · Tests: Focused shockwave, Radial wave, Sham treatment SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer NCT05412082Phase 11 site📍 Miami University of Miami · Tests: Intensity-modulated radiation therapy, 5-fluorouracil, Leucovorin, Oxaliplatin, Capecitabine Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies NCT05457595NA1 site📍 Pavia CNAO National Center of Oncological Hadrontherapy · Tests: carbon ion radiation therapy Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study NCT05987241Phase 2, Phase 3505 sites📍 Phoenix📍 Phoenix📍 Tucson National Cancer Institute (NCI) · Tests: Biospecimen Collection, cfDNA or ctDNA Measurement, Computed Tomography, Cystoscopy, Magnetic Resonance Imaging The Effect of Mobile-Based Perioperative Education on Urinary Incontinence and Erectile Function After Radical Prostatectomy NCT07520916NA1 site📍 Giresun Giresun University · Tests: Mobile-Based Perioperative Education Program, Standard Perioperative Care EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: EBNK-001 + IL-15 + Pembrolizumab Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy NCT07234968NA2 sites📍 Philadelphia📍 Philadelphia Thomas Jefferson University · Tests: Ureteral Stent Placement, No Ureteral Stent, Indocyanine Green with Fluorescence Imaging Prospective Clinical Trial on the Impact of Uterine Firomatosis on Pelvic Floor. NCT07180524n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia BladdEr Full OR Empty for Pelvic Radiation Therapy NCT06651697Phase 31 site📍 San Diego University of California, San Diego · Tests: Radiation therapy Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery. NCT07483658NA4 sites📍 Gatineau📍 Montreal📍 Montreal CHU de Quebec-Universite Laval · Tests: Standard Fractionation Post-Operative Salvage Radiotherapy (25 fractions), Hypofractionated Post-Operative Salvage Radi… Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy NCT06997887NA1 site📍 Taipei National Taiwan University Hospital · Tests: CH2 vaginal gel, vaginal rehabilitation exercises Hypofractionated WPPT With HDR Boost NCT06591819Phase 21 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Hypofractionated Whole Pelvis Proton Therapy with Brachytherapy Boost HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation NCT07786493NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: High-Dose-Rate Endorectal Brachytherapy Ketogenic Diet Compliance in Patients Undergoing Radiotherapy for Pelvic Cancers NCT05938322NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Ketogenic Diet, Standard Diet A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors NCT06465069Phase 139 sites📍 Duarte📍 La Jolla📍 Los Angeles Eli Lilly and Company · Tests: LY4052031, Pembrolizumab 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma NCT06823427Phase 22 sites📍 Changsha📍 Nanjing Mabwell (Shanghai) Bioscience Co., Ltd. · Tests: 9MW2821, Toripalimab (JS001 ) Advanced Pelvic Surgical Oncology Database - Prospective Observational Study NCT05696002n/a1 site📍 Glasgow Glasgow Royal Infirmary Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients NCT05705219n/a3 sites📍 Palo Alto📍 San Diego📍 Philadelphia University of California, San Diego · Tests: 3D-MPUS Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms NCT07397715n/a5 sites📍 Leuven📍 Sosnowiec📍 Barcelona Swiss GO Trial Group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy